Risk of rash and stomatitis with temsirolimus, a mammalian target of rapamycin (mTOR) inhibitor: A meta-analysis.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: C. Gomez Fernandez, Y. Balagula, S. Wu, X. Su, D. R. Feldman, D. E. Rathkopf, M. E. Lacouture
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2257415508